Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Imran Zainal Abidin, Ciaran J. McMullan et al.|The Lancet|2025Cited by 77
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial DataLeah Andrews, María L. Alcaide, Jessica Andriesen et al.|JAMA Network Open|2025Cited by 6